June 11, 2010 Coalition Against Major Diseases Introduces the First Combined Pharmaceutical Trial Data on Neuro-degenerative Diseases A new database of more than 4,000 Alzheimer’s disease patients who have participated in 11 industry-sponsored clinical trial
June 11, 2010 Critical Path Institute’s Predictive Safety Testing Consortium Announces First-Ever Qualification Decision by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). For the first time, new biomarker tests to detect drug-induced kidney injury have been accepted by the Japanese Pharmaceuticals an
May 11, 2010 Critical Path Institute’s Predictive Safety Testing Consortium Announces Special Issue of Nature Biotechnology Dedicated to Newly Qualified Kidney Safety Biomarkers A special May 10, 2010 issue of Nature Biotechnology (NBT) includes ten scientific publications from Critical Path Institute’
May 11, 2010 Urinary Biomarkers Trefoil Factor 3 and Albumin Enable Early Detection of Kidney Tubular Injury
May 11, 2010 Kidney injury Molecule-1 Outperforms Traditional Biomarkers of Kidney Injury in Preclinical Biomarker Qualification Studies
May 11, 2010 Towards Consensus Practices to Qualify Safety Biomarkers for Use in Early Drug Development
May 11, 2010 A Panel of Urinary Biomarkers to Monitor Reversibility of Renal Injury and a Serum Marker with Improved Potential to Assess Renal Function
